Zolotarov, Yevgen
Ma, Chao
González-Recio, Irene
Hardy, Serge
Franken, Gijs A. C.
Uetani, Noriko
Latta, Femke
Kostantin, Elie
Boulais, Jonathan
Thibault, Marie-Pier
Côté, Jean-François
Díaz-Moreno, Irene
Quintana, Antonio Díaz
Hoenderop, Joost G. J.
Martínez-Cruz, Luis Alfonso
Tremblay, Michel L. http://orcid.org/0000-0002-0281-541X
de Baaij, Jeroen H. F.
Funding for this research was provided by:
Fonds de Recherche du Québec - Santé (PhD Scholarship, #294027)
European Joint Program for Rare Disease (EJPRD2019-40)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO Veni 016.186.012. Vici 016.130.668)
Dutch Diabetes Research Foundation (2017.81.014)
Ministerio de Ciencia, Innovación y Universidades (PGC2018-096049-B-I00)
Andalusian Government (BIO-198, US-1254317 and US-1257019)
Canadian Institutes of Health Research (ERT-168503, MOP-142497 and FDN-159923)
European Union's Horizon 2020 research and innovation programme (EJP RD COFUND-EJP N° 825575)
Article History
Received: 9 September 2020
Revised: 23 March 2021
Accepted: 30 March 2021
First Online: 5 June 2021
Change Date: 8 August 2021
Change Type: Update
Change Details: The original online version of this article was revised due to error in author name Irene Díaz-Moreno
Declarations
:
: The authors declare that they have no conflict of interest.
: The animals were housed at the Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands, according the institutional guidelines. The study was ethically approved by the Local Ethical Committee of the Radboud University Nijmegen (RU DEC 2015-0112) and by the Dutch Central Commission for Animal Experiments (CCD, AVD103002016382).